key: cord-262673-j2ot35lt authors: Ahmed-Hassan, Hanaa; Sisson, Brianna; Shukla, Rajni Kant; Wijewantha, Yasasvi; Funderburg, Nicholas T.; Li, Zihai; Hayes, Don; Demberg, Thorsten; Liyanage, Namal P. M. title: Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections date: 2020-08-18 journal: Front Immunol DOI: 10.3389/fimmu.2020.01979 sha: doc_id: 262673 cord_uid: j2ot35lt The new pandemic virus SARS-CoV-2 emerged in China and spread around the world in <3 months, infecting millions of people, and causing countries to shut down public life and businesses. Nearly all nations were unprepared for this pandemic with healthcare systems stretched to their limits due to the lack of an effective vaccine and treatment. Infection with SARS-CoV-2 can lead to Coronavirus disease 2019 (COVID-19). COVID-19 is respiratory disease that can result in a cytokine storm with stark differences in morbidity and mortality between younger and older patient populations. Details regarding mechanisms of viral entry via the respiratory system and immune system correlates of protection or pathogenesis have not been fully elucidated. Here, we provide an overview of the innate immune responses in the lung to the coronaviruses MERS-CoV, SARS-CoV, and SARS-CoV-2. This review provides insight into key innate immune mechanisms that will aid in the development of therapeutics and preventive vaccines for SARS-CoV-2 infection. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) reportedly emerged at a live animal market in the Chinese city of Wuhan is currently causing a pandemic and negatively affecting global health (1) (2) (3) . There are more than 11 million confirmed SARS-CoV-2 infections with an mortality rate that widely varies by country and region (4) . Even in industrialized countries, SARS-CoV-2 led healthcare systems approach the brink of collapse by overwhelming their capacity and straining resources. Governments and local leaders ordered the shutdown of cities, regions, countries leading to massive disruptions in the local and global economy. Unlike previous Coronavirus (CoV) infections, the rapid global spread, high transmission rate, longer incubation time, and disease severity of SARS-CoV-2 requires a better understanding of the epidemiology and immunopathogenesis of this viral outbreak in order to learn from this experience and to manage future pandemics. SARS-CoV-2 is a highly pathogenic CoV (5) (case-fatality rate of 3.6-3.8%) (4, 6) that is related to Severe Acute Respiratory Syndrome CoV (SARS-CoV) (case-fatality rate of 14-15%) and the Middle East Respiratory Syndrome CoV (MERS-CoV) (case-fatality rate of 34.4%), see also Table 1 (138, 139) . SARS-CoV, SARS-CoV-2 and MERS-CoV target the lower respiratory system, causing respiratory illnesses, including severe pneumonia, acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) (140, 141) . SARS-CoV-2 infection results in higher hospitalization rates in the elderly (>65) and persons with pre-existing conditions including hypertension, diabetes and obesity compared to rates among younger populations without pre-existing conditions ( Table 1 ) (142, 143) . In addition to an age disparity, males with COVID-19 appear to have higher risk for worse outcomes and death (143, 144) . Epidemiological research of the SARS and MERS infections also showed that males had a higher mortality rate than females (144) (145) (146) . While SARS-CoV-2 is a novel coronavirus, several important insights have already been made about its basic mode of transmission. Virus particles are inhaled in respiratory droplets expelled from the airways of infected individuals. Angiotensinconverting enzyme 2 (ACE2), expressed on the ciliated bronchial cells, endothelial cells, and type I and II alveolar cells, is the host receptor for cell entry into the respiratory tract by both SARS-CoV-2 and SARS-CoV ( Table 1 ) (147) (148) (149) (150) . The spike protein (S) of CoV is responsible for the entry of the virus into the target cell (Figure 1 ) (147, 151) . ACE2 is a type I transmembrane metallocarboxypeptidase that plays a vital role in the Renin-Angiotensin System (RAS) (152, 153) , which in turn is critical in maintaining blood pressure homeostasis as well as fluid and salt balance in mammals. ACE2 is found in vascular endothelial cells, in the renal tubular epithelium, and in Leydig cells of the testes (154) . Studies have shown that ACE2 is expressed in gastrointestinal (GI) tissues, making it a potential site for harboring SARS-CoV (155) . This may be one of the reasons for GI pathology reported in some patients with COVID-19 and viral shedding in stool. In contrast, MERS-CoV uses dipeptidyl-peptidase 4 (DPP4) as an entry receptor, which is expressed on endothelial cells and some epithelial tissues ( Table 1 ) (19, 156) . Accumulating data suggest that the innate anti-viral response and adaptive immunity may contribute to a cytokine storm leading to systemic hyper inflammation and exacerbation of the disease in patients with (a) comorbidities (b) older than 65 years of age (c) of the male sex. The exact role of the innate immune system in disease pathogenesis and prevention between the sexes and the impact of age is not fully elucidated. In addition, the potential dysregulation of the innate immune response by SARS-CoV and SARS-CoV-2 is not completely understood which warrants further research. The cells of the airway epithelium are the first line of defense, providing a mechanical barrier (mucociliary escalator) that expels particles and pathogens via cilia, mucus, and induced coughing (157, 158) . This barrier includes cells of the pulmonary epithelium and tissue-resident macrophages and dendritic cells (DCs). The macrophages and DCs express pattern recognition receptors (PRRs) that can detect molecules from pathogens (Pathogen-Associated Molecular Patterns-PAMPs) or molecules released from damaged cells (Damage or Danger-Associated Molecular Patterns-DAMPs) (158) (159) (160) . In the lung, there are two populations of macrophages, alveolar and interstitial macrophages (161) . In addition to these macrophages, DCs play a vital role in facilitating the host defenses against respiratory diseases (162) (163) (164) . DCs can be divided into plasmacytoid (pDC) and myeloid types (mDC) (165) (166) (167) . Macrophages and the two DC subtypes trigger antiviral responses by generating a substantial amount of type I interferon and these cells play important roles in immune surveillance in the airways and the distal lung (74, (168) (169) (170) (171) (172) . During steady state, the DC density in lung associated tissue declines from the trachea to the alveoli (173) while the representation of cells in macrophage compartment seems more complex (174) . If a virus infects airway epithelial cells, the viral RNA would be sensed via intrinsic innate receptors, including RIG-1, MDA5, NLRP3 inflammasome, and the RNA sensing TLRs 7 and 8. In the case of influenza A infection, triggering the PRRs causes a strong induction of type 1 interferon (IFN) in epithelial cells (175, 176) . In other viral infections, such as Respiratory Syncytial Virus (RSV), alveolar macrophages are the predominant source of type 1 IFNs (161). Furthermore, respiratory epithelial cells and lung macrophages are capable of secreting a broad range of chemokines like IL-8, Macrophage inflammatory protein-1 (MIP-1), RANTES and cytokines including TNF-α, IL-6, IL-1β that influence the types of immune cells being recruited to the area in response to acute viral infections (177, 178) . Macrophages, depending on their polarization status of either M1 or M2, and in a similar way as airway epithelial cells, can further elicit a Th1 or Th2 response (158, 161, 178) . In the case of influenza virus infection, the magnitude of epithelial cell response can be proportional to the amount of virus which result in paracrine induction of IFN λ (175) . Not only can airway epithelial cells produce a large array of cytokines/chemokines in response to an acute viral infection, but, depending on the magnitude of PRR engagement and the combination of PAMPs and DAMPs triggered, these epithelial cells can modulate the type of chemokines/cytokines produced and influence the influx of innate and adaptive immune cells (158, 160) . The response to different viral infections is generally similar, however, the response can be tailored in timing, magnitude and the induced gene signatures in response to each virus (179) . Unlike RSV and MERS-CoV, which both productively infect alveolar Multiple cell types in the lower respiratory tract were found to be infected, including type I alveolar epithelium, macrophages, and putative CD34 + Oct-4 + stem/progenitor cells in human lungs (15) (16) (17) Ciliated bronchial epithelial cells and type II pneumocytes (7, 18) Un-ciliated bronchial epithelial cells and type II pneumocytes (19) (20) (21) Infect mostly human type I and type II pneumocytes and alveolar macrophages (22) Respiratory, nasal, corneal and intestinal epithelial cells (23) Club cells, ciliated cells, type I and type II alveolar cells (24) Ciliated epithelial cells of the upper and lower respiratory tract (25) The ciliated cells of the human airway epithelium are the main target, it also infects basal cells (26) and immune cells, such as Macrophages, B cells CD4 + and CD8 + T cells (27) Upper and lower airways epithelial cell ( No specific antiviral drugs (134) Antiviral drugs may be a treatment option (135) No antiviral agents symptomatic treatment Supportive care (136) There are no approved antiviral medications (137) ACE2 macrophages (73, 180) , seasonal influenza and SARS-CoV usually lead to non-productive infections in these cells (181) . In addition, SARS-CoV infection of primary monocytes yielded little virus, likely due to the suppressive effects of IFN-α (182) . Thus, the initial cell type(s) involved in propagating a viral infection intensifies the complexity of the immune response. Another key factor that determines the magnitude of the immune response is the induction and rate of cell death. Although related, MERS-CoV induces widespread cell death when compared to SARS-CoV in human bronchial epithelial cell cultures (183) . However, the SARS-CoV open reading frame 3a (ORF3a) protein can induced necrotic cell death in a variety of cell lines (184) . The same ORF3a protein can activate the NLRP3 inflammasome, leading to activation of NF-κB and elevated secretion of active IL-1β in cell culture (185) . Cytokine (186), with slightly different cytokine/chemokine profiles. This delay in cytokine induction was confirmed in another study using the same epithelial cell lines (187) as well as in human alveolar type II cells (18) . In both cell lines and primary alveolar type II cells, SARS-CoV induced IFN-β, IFN-λ, CXCL10, CXCL11, IL-6, IP-10, and TNF-α (18, 187) . MERS-CoV did not induce IFN-β but induced higher level of IL-8 transcript in cell culture. However, no difference in IL-8 production was observed between SARS-CoV and MERS-CoV at 48 h post-infection (186) . This was confirmed in-vivo using a non-human primate model comparing the immune responses to SARS-CoV infection between young adult cynomolgus macaques (3-5 yrs) and older macaques (10-19 yrs) (188) . Interestingly, the high induction of IL-8 was observed on a transcript level in the older animals, while the younger once showed higher levels of IFN-β transcript (188) . In all animals, the expression of IFN-β was inversely correlated with the pathology score, supporting the role of IFN-β in controlling disease severity (188) and introducing a potential area of research to define age disparity observed in patients infected with SARS-CoV-2. Both older age and male sex are important factors associated with high mortality of SARS-CoV and SARS-CoV-2 infection (189, 190) . Many viruses have evolved to disrupt and subvert the immune responses. A common virus that is well-known to affect the lower airway and counteract the immune response is RSV (178, 191) . The RSV genome encodes non-structural proteins NS1 and NS2 that can block type 1 IFN production and signaling in cell cultures (191) . Similar to RSV, the Measle virus V protein blocks IFN-α and β signaling by inhibiting Stat1 and Stat2 signaling in cell lines (192) , whereas MERS-CoV M protein also suppresses type 1 IFN by inactivating IRF3 (193) , leading to the low expression of IFN-β. In contrast to reports in epithelial cell lines or primary alveolar type II cell culture and observations in non-human primates, SARS-CoV nucleocapsid (N) protein and membrane (M) protein, as well as nsp1, can suppress IFN response via various mechanisms in cell lines (194) (195) (196) . To bridge the dichotomy of inhibition of IFN signaling in cell lines, and the IFN expression in vivo, cells recruited by the infection need to be considered as a potential source. As previously discussed, infected epithelial cells via paracrine signaling to neighboring cells and resident macrophages, secrete chemokines and cytokines to attract other immune cells. In general, monocytes/macrophages are recruited by CCL3 (MIP-1a), CCL2 (MCP-1), and neutrophils are recruited by IL-8 (CXCL8), CXCL2, and CXCL5 chemokines, all of which can be secreted by airway epithelial cells (178, 197, 198) . Both monocytes and neutrophils are also recruited by complement fragment (anaphylatoxin) C5a (Figure 1) . Both Influenza and SARS virus can induce acute lung injury (ALI) which is accompanied by high levels of C5a, leading to the influx and activation of innate immune cells (199) (Figure 1) . Serum samples and lung tissue of SARS patients showed high-level expression of CXCL10 (IP-10), which is also found to be induced by SARS-CoV in the epithelial cell line Calu-3 (200) . Significant neutrophil, macrophage and CD8 T-cell infiltration can be found in the lung of SARS patients by immunohistochemistry (76, 77, 201) . In addition to post-mortem lung histology analysis in patients with SARS-CoV, experiments using Rhesus macaques infected with SARS-CoV found monocyte and macrophage recruitment. The accumulation of pathogenic inflammatory monocytemacrophages (IMMs) was also observed in a SARS-CoV mouse model. The accumulation of IMMs resulted in heightened lung inflammatory cytokine/chemokine levels, extensive vascular leakage, and impaired virus-specific T cell responses (202) . A strong infiltration of CD68 and Mac387 positive monocytes/macrophages were found in the human and animals lung samples (203, 204) . Macrophages further stimulate fibroblasts to deposit extracellular matrix leading to pulmonary fibrosis (205) , which was also observed in patients who recovered from SARS (206, 207) . Autopsy samples acquired from patients with SARS-CoV-2 patients contained viral nucleocapsid protein (NP) positive CD68 + macrophages in the capillaries of the spleen and in lymph nodes, indicating that SARS-CoV-2 might migrate into the spleen and lymph nodes through macrophages. This study also found that CD169 + macrophages appear to mediate SARS-CoV-2 into these tissue sites, contributing to virus dissemination (208) . Similar to SARS-CoV-2, SARS viral particles and genomic sequences were detected in monocytes, macrophages as well as within different organs of SARS patients (15) . SARS-CoV was shown to infect both immature and mature human monocyte-derived DCs by electron microscopy and immunofluorescence. The detection of negative strands of SARS-CoV RNA in DCs suggests viral replication, but no increase in viral RNA was observed (209) . As mentioned above, there was no perceivable increase to SARS-CoV replication in primary monocytes (182) . Another study looked at SARS-CoV and MERS-CoV replication in human macrophages, human monocyte-derived macrophages, and dendritic cells (MDDCs) and found that both viruses replicated poorly. MERS-CoV induced IFN-λ1, CXCL10, and MxA mRNAs in both macrophages and MDDCs, however, SARS-CoV was unable to induce such responses (69) . Interestingly, depletion of inflammatory monocyte-macrophages in the mouse model partially protected from lethal SARS infection (210) . These data suggest that monocytes, macrophages and dendritic cells have essential roles in CoV infection. The severity of disease and the response to these viruses seems to be dependent on the induced cytokine/chemokine profiles and the amplification of the immune response by the recruited cells. Growing evidence of dysregulation of an innate anti-viral response originates from studies using clinical samples (211) and murine models (202, 212, 213) . In addition to dysregulated cellular responses, the complement system may play an important role in SARS-CoV-2 infection (Figure 1) . Evidence comes from SARS infected patients who had lower levels of mannan binding lectin (MBL) in serum compared to healthy controls (214) . The SARS patients with a higher frequency of MBL gene polymorphisms were associated with lower serum levels or deficiency of MBL (214) . It is still unknown if this is also true for COVID-19 patients, which requires further investigation. In cell culture experiments SARS-CoV was able to bind and activate the complement cascade and block viral infection (214) . Preliminary findings in a limited number COVID-19 patients found significant deposits of the membrane attack complex (MAC), C4d and MBL-associated serine protease (MASP)2 in the microvasculature indicating sustained, systemic activation (215) . The SARS-CoV-2 spike protein was co-localized with C4d and MAC (215) . In a non-peer reviewed publication by Gao et al., MERS-CoV, SARS-CoV and SARS-CoV-2 N protein are able to bind to MASP-2 leading to enhanced complement activation (216) (Figure 1) . In a later phase of the infection, the complement system might be also triggered via antibodies bound to the virus (Classic activation pathway, Figure 1 ). This excessive complement activation might play a role in multi organ damage in severe COVID-19 cases (217) . In a MERS-CoV mouse model the blockade of the C5a-C5aR axis alleviated not only lung damage but also spleen damage (218) . Mice treated with a monoclonal antibody to C5a showed reduced lung infiltration of CD68 + cells and significantly lower cytokine levels of IL-1 β, TNF-α, INF-γ and IL-12 (218) . Complement blockade might be an important way to curb part of the immune dysregulation associated with COVID-19. Overall, we need to look closer at the role of the complement system, the recruited innate immune cells and their combined role in pathogenesis, viral clearance and the eventual resolution of the infection. The most abundant leukocytes, neutrophils, play a critical role in clearing viral infections. Neutrophils, attracted by chemokines/cytokines released by tissue-resident macrophages and DCs, swarm to the site of infection. They recognize and release bioactive compounds, including cytokines, chemokines and ROS, as well as NOS in the very early phase of the infection (219, 220) . Neutrophils modulate other innate and adaptive immune responses via cytokine/chemokine release and cell death and, therefore, can ameliorate or exacerbate disease progression. Neutrophils infiltrate tissues infected by CoV, including SARS-CoV, Rat coronavirus (rCoV), and Mouse Hepatitis Virus (MHV). A high neutrophil count in the blood of SARS patients at the time of hospital admission is associated with a poor prognosis (221, 222) . Gao et al. suggested that patients with SARS-CoV-2 pneumonia can be stratified by neutrophil to lymphocyte ratio (NLR) and age (216) . Patients older than 50 years of age and having an NLR ≥ 3.13 had more severe illness, so rapid access to the intensive care unit is required (79, 223) . Experiments in mice showed that SARS-CoV disease severity in older mice correlated with increased pulmonary inflammation and influx of neutrophils (224, 225) . Infection of rats with rCoV could lead to neutrophil infiltrating into the respiratory tract early after inoculation, followed by the recruitment of macrophages and lymphocytes (226) . Infection of mice with a neurotropic murine CoV (MHV-JHM) showed infiltration of neutrophils into the brain as early as the first day after inoculation, which then promoted the recruitment of other types of inflammatory cells into the brain, likely through the loss of the blood-brain barrier integrity (227) . Gene expression analysis in experimentally infected rhesus macaques with MERS-CoV revealed the recruitment of neutrophils into infected lung tissue (228, 229) . Angiotensin-converting enzyme inhibitors (ACE-Is) could serve as a potential risk for fatal COVID-19 through the upregulation of ACE2 (230) and may provide a direct linkage to neutrophils and disease progression. Investigators found that ACE2 modulates IL-17-mediated neutrophil influx by impacting STAT3 activity (231) . Animal models used to study the pathogenesis of SARS-CoV-2 have revealed important roles of neutrophils in infection and confirmed findings observed in patients. A new aspect in SARS-CoV-2 infection is the potential role of neutrophil extracellular traps (NETs). The process of NET formation is a specific type of cell death that can be triggered under inflammatory conditions (232, 233) , such as GM-CSF+C5a, IL-8, IFN-α+C5a or other TLR response mediators; all conditions present in severe SARS-CoV-2 infection (232, 233) . The NET formation has been observed in COVID-19 patients and may contribute to thrombotic complications in COVID-19 patients (234, 235) . Microvascular injury and thrombosis have been reported in COVID-19 patients, increasing the likelihood that neutrophil NET formation might play a role (215, 236, 237) . NET formation was reported to be involved in clot formation and thrombosis and can further increase inflammation (232, 233) . Therefore, neutrophils can attract a second wave of immune cells to the site of infection by cytokine/chemokine secretion as well as via NETosis (238, 239) , which included monocytes and natural killer cells. On the other hand aggregated NETs were reported to limit inflammation by degrading cytokines and chemokines and disrupting neutrophil recruitment and activation (240) . Despite the presence of neutrophils in SARS-CoV-2-infected tissues, their role in the clearance and/or immunopathology of the viral infection remains unclear. Future studies on the responses of neutrophils to SARS-CoV-2-infection or infected cells in vitro may elucidate the role of neutrophils in the pathogenesis of respiratory CoV infections. Natural Killer (NK) cells are a heterogenic immune cell subset that acts promptly to combat viral infections. They produce significant amounts of IFN-γ, kill virus-infected cells, provide direct support to other innate immune cells, and aid in the adaptive immune response to counter viruses. NK cells express activating receptors that detect viral antigens, enabling the destruction of infected cells (241) (242) (243) (244) . Lectin-like receptor CD94 and killer immunoglobulin-like receptors, such as CD158b, regulate the function of NK cells. A study of 221 patients with SARS explored the relationship of the number of NK cells and the expression level of their immunoglobulin-like receptor CD158b in the peripheral blood to the severity of SARS (245) . The overall count of NK cells and CD158 + NK cells and the percentage of CD158 + NK cells in patients with SARS were significantly lower than counts in healthy subjects (245) . A separate study that analyzed lymphocytes and lymphocyte subsets in a cohort of 38 patients with SARS observed reduced NK cell counts in 21 patients (55%) (246) . Clinical reports reveal that children appear to have a milder form of SARS-CoV-2, with peripheral blood lymphocyte levels remaining in the normal range, suggesting less immune dysfunction following the disease (247) . This could be attributed to healthy children expressing lymphocytes, especially NK cells, in a greater quantity compared to healthy adults (248) . Interestingly, previous studies found rapid and significant restoration of lymphocyte subsets including, NK cells, in peripheral blood in patients recovering from the initial stages of SARS infection (249) . Although the primary mechanism for the decrease in NK cells and other subsets during disease onset remains unknown, their contribution to SARS-CoV-2 needs further study especially from a treatment perspective. Innate lymphoid cells (ILCs) are a family of innate immune cells that include ILC1, ILC2 and ILC3. Although ILC2 facilitates lung repair after injury, the role of ILCs during respiratory viral infection is not clearly defined (250) . Evidence for the potential involvement of ILC2 cells in the lung during viral infection was reported in a murine model (251) . This study found a rapid accumulation of ILC2 cells in the lung after an influenza virus infection, however their initial contribution to exacerbation of the disease was limited (251) . A recent study identified an interaction between ACE2-expressing SARS-CoV-2 target cells and ILCs in the colon (252) . Thus, elucidating the role of ILC subsets will be important in understanding the pathogenesis of SARS, SARS-CoV-2 and MERS infections. There is distinct evidence indicating an important role of IFNs in SARS and other CoV infections (201, 253) . The sera of patients with SARS revealed the presence of high levels of IL-1, IL-6, INFγ, CCL2, CXCL10, and IL-8 and products of interferon stimulated genes (254, 255) . High expression levels of ISGs such as CD58, IFNAR1, and IFNGR1 and IFN-stimulated chemokines CXCL10 and CCL2 were observed in another cohort of SARS patients and were correlated with the severity of pathogenesis (256) . Significant upregulation of CXCL10 gene expression was observed in the severe phase of patients who died from SARS. This data is corroborated by studies in patients with MERS that found upregulation of CXCL10 in the serum of patients who developed pneumonia (254) . CXCL10 and INFα were also correlated with severity of disease (255) . The importance of IFN signaling in response to CoV infection has been well-demonstrated in several knockout mouse models. Type I, II, and III IFN signaling deficient mice have increased susceptibility to mouse-adapted SARS-CoV strains (257, 258) . Studies using mice lacking the IFNAR1 and IFNLR1 or STAT1 identified higher SARS-CoV replication in the lungs and delayed virus clearance (259, 260) . Another study with MERS-CoV in mice expressing the human DPP4 receptor showed a role for the IFNAR1 in viral clearance and lung inflammation (112) . These mouse models suggest an important role of IFN response for CoV clearance. This quick expanding medical literature is very suggestive of an important role of IFN responses for CoV control and clearance. Many viruses have evolved to disrupt and subvert the immune response. RSV counteracts the immune response (178, 191) ; as discussed earlier, the RSV genome encodes non-structural proteins (NS1 and NS2) that are able to block type 1 IFN production and signaling in cell cultures (191) . Similar to RSV, the Measle virus V protein blocks IFN-α and β signaling by inhibiting Stat1 and Stat2 signaling in cell culture lines (192) . CoVs have developed several ways to escape from innate immune pressure. MERS-CoV M protein suppresses type 1 IFN by blocking the IRF3 activation (193) , explaining the low expression of IFN-β. In various cell lines, SARS-CoV nucleocapsid (N) protein, membrane (M) protein, as well as nsp1, were reported to suppress IFN response (194, 196, 261) . The nucleocapsid protein (N) of SARS-CoV interferes with the function of IRF3. Although it does not form a complex with RIG-I or MDA5, RNA binding activity at the initial recognition stage of viral RNA potentially contributes to immune evasion (261, 262) . Aside from the HCoV, structural proteins, accessory, and non-structural proteins (nsp) are involved in innate immunity modulation. In both SARS-CoV and MERS-CoV, host mRNA endonucleolytic cleavage is promoted by nsp1 protein, which modifies capped non-viral RNAs (263, 264) . Nsp1 in SARS-CoV prevents host mRNA translation by interacting with the 40S subunit of the ribosome; in turn, transcription and translation of viral RNA is given preference over the host mRNA (263) . Another study found that additional SARS-CoV nsp1 residues interfered with IFN-dependent signaling (265) . IFN production is affected by nsp3 proteins in SARS-CoV and MERS-CoV. These proteins have both papain-like protease (PLpro) and a PLP2 domain, and the PLpro domains in both SARS-CoV and MERS-CoV downregulate mRNA levels of CCL5, INFβ, CXCL10, and other pro-inflammatory cytokines (266) . The suppression of IFN responses by SARS-CoV PLpro is due to the inhibition of phosphorylation of IFN-regulatory factor 3 (IRF3) and its subsequent translocation to the nucleus where it enhances IFN gene transcription (267) . MERS-CoV PLpro also suppresses RIG-I and MDA5 and antagonizes IFN induction (266, 268) . In HCoV-229E and SARS-CoV suppression of IFN responses, the key molecule is a ADP-ribose-1-monophosphatase macrodomain encoded within nsp3 (269) . Accessory proteins are not key in viral replication; however, in human CoV, this group of proteins are involved in diverse cellular signaling, including cell proliferation, apoptosis, and IFN signaling (270) . By downregulating phosphorylation and nuclear translocation of IRF3, Open Reading Frame ORF3b and -6 interfere with IFNβ synthesis and prevent IFNβ-induced activation of IFNstimulated response element (ISRE) in the promoter of ISG in SARS-CoV (262) . In cells transfected with ORF4a, -4b, and -5 of MERS-CoV, IFNβ promoter-driven luciferase activity is significantly reduced, and it may follow a similar pattern of suppression of IRF3 nuclear translocation (141) . Therefore, the suppression of signaling events in infected immune and airway epithelial cells, as well as the magnitude of suppression due to elevated expression levels of these accessory proteins, needs to be further elucidated to understand delayed or hyperimmune responses and cytokine storm that occurs in CoV infection. In addition to revealing our unpreparedness of handling a worldwide pandemic by a viral infection, COVID-19 exposed our lack of understanding of the pathogenesis of diseases as well as the host immunity. The interaction of the host innate immune system and other factors including age, sex, and pre-existing conditions need further investigation regarding disease severity and morbidity of SARS/MERS and COVID-19. Disease severity and its related progression are further associated with dysregulation of multiple components of both innate and adaptive immune responses leading to a cytokine storm and severe pathology. For the development of a therapeutic intervention, it is vital to elucidate the interplay among the different layers of the innate immune response and their relation to the clinical factors associated with increased morbidity and mortality in CoV infection. Investments in basic science research are needed to help elucidate the roles of different immune cells, and their contribution to disease severity; it will pave the way to prevent or abrogate CoV outbreaks and potentially new viruses. NL, TD, DH, ZL, and NF performed the literature search, analyzed the literature, and wrote the manuscript. HA-H, BS, YW, and RS performed the literature search and wrote the manuscript. All authors contributed to the article and approved the submitted version. A novel coronavirus outbreak of global health concern A novel coronavirus from patients with pneumonia in China Korean Society of Epidemiology -nCo VTFT. An interim review of the epidemiological characteristics of 2019 novel coronavirus Cross-country comparison of case fatality rates of COVID-19/SARS-COV-2. Osong Public Health Res Perspect Understanding of COVID-19 based on current evidence Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel Coronavirus Disease 2019. (COVID-19) Angiotensinconverting enzyme 2 is a functional receptor for the SARS coronavirus Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4 Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike. iScience The sialic acid binding activity of human parainfluenza virus 3 and mumps virus glycoproteins enhances the adherence of group b streptococci to HEp-2 Cells CX3CR1 as a respiratory syncytial virus receptor in pediatric human lung Rhinoviruses and their receptors Multiple organ infection and the pathogenesis of SARS A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC Anaesthetic and medico-legal problems in patients intoxicated by alcohol Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19 SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes Investigating influenza A virus infection: tools to track infection and limit tropism Parainfluenza virus infection Respiratory syncytial virus can infect basal cells and alter human airway epithelial differentiation Respiratory Syncytial Virus (RSV) infects CD4+ T cells: frequency of circulating CD4+ RSV+ T cells as a marker of disease severity in young children The emerging role of rhinoviruses in lower respiratory tract infections in children -clinical and molecular epidemiological study from Croatia Summary Table of SARS Cases by Country Q&A: Influenza and COVID-19 -Similarities and Differences Epidemiology of acute respiratory infections in children of developing countries 2019 Case Definition Coronavirus as a possible cause of severe acute respiratory syndrome Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia Association between age and clinical characteristics and outcomes of COVID-19 Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries Human parainfluenza virus 4 outbreak and the role of diagnostic tests Age-specific incidence rates and risk factors for respiratory syncytial virusassociated lower respiratory tract illness in cohort children under 5 years old in the Philippines. Influenza Other Respir Viruses Respiratory syncytial virus infection in adults Human rhinovirus C: Age, season, and lower respiratory illness over the past 3 decades WHO. Consensus Document on the Epidemiology of Severe Acute Respiratory Syndrome (SARS) WHO. Contract MERS transmission and risk factors: a systematic review Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature Transmission of respiratory syncytial virus among children under 5 years in households of rural communities, the Philippines Lethal respiratory disease associated with human rhinovirus C in wild chimpanzees Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia Incubation period and other epidemiological characteristics of 2019. Novel coronavirus infections with right truncation: a statistical analysis of publicly available case data Incubation periods of acute respiratory viral infections: a systematic review Human Parainfluenza Viruses (HPIVs) Available online at Transmission dynamics and control of severe acute respiratory syndrome Q&As on COVID-19 and Related Health Topics Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area Acute renal impairment in coronavirus-associated severe acute respiratory syndrome Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study Respiratory tract cell-mediated immunity Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis Hospitalized patients with 2009. H1N1 influenza in the United States Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults Respiratory syncytial virus infection in elderly and high-risk adults Clinical characteristics and outcomes of human rhinovirus positivity in hospitalized children Detection of human rhinoviruses in the lower respiratory tract of lung transplant recipients Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocytederived macrophages and dendritic cells Macrophages: a Trojan horse in COVID-19? Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections Activation of human macrophages by bacterial components relieves the restriction on replication of an interferon-inducing parainfluenza virus 5 (PIV5) P/V mutant Productive infection of isolated human alveolar macrophages by respiratory syncytial virus Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes Rhinovirus replication in human macrophages induces NF-kappaBdependent tumor necrosis factor alpha production SARS-CoV regulates immune function-related gene expression in human monocytic cells Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells Dysregulation of immune response in patients with COVID-19 in Wuhan, China Depressed human monocyte function after influenza infection in vitro Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3 Human airway epithelial cells direct significant rhinovirus replication in monocytic cells by enhancing ICAM1 Expression Productive replication of Middle East respiratory syndrome coronavirus in monocytederived dendritic cells modulates innate immune response Heightened innate immune responses in the respiratory tract of COVID-19 patients Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells Human parainfluenza virus type 2 vector induces dendritic cell maturation without viral RNA replication/transcription Innate immune components that regulate the pathogenesis and resolution of hRSV and hMPV infections Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract Innate immunity to influenza virus infection Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis Chemokines and inflammation in the nasal passages of infants with respiratory syncytial virus bronchiolitis Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways High levels of virus-specific CD4+ T cells predict severe pandemic influenza A virus infection Infection and immunoregulation of T lymphocytes by parainfluenza virus type 3 Protective and dysregulated T cell immunity in RSV infection Rhinovirus has the unique ability to directly activate human T cells in vitro Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study Middle East Respiratory Syndrome Coronavirus (MERS-CoV): infection, immunological response, and vaccine development Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19 A B cell population that dominates the primary response to influenza virus hemagglutinin does not participate in the memory response B-cell fate decisions following influenza virus infection Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response Innate immune signals modulate antiviral and polyreactive antibody responses during severe respiratory syncytial virus infection Peripheral blood T and B lymphocyte subpopulations in infants with acute respiratory syncytial virus brochiolitis Human rhinoviruses enter and induce proliferation of B lymphocytes Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes Rapid generation of a mouse model for Middle East respiratory syndrome Persistence of antibodies against Middle East respiratory syndrome coronavirus Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses Protective antibodies against influenza proteins Protective effect of antibody to parainfluenza type 1 virus Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze The time course of the humoral immune response to rhinovirus infection Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome The relationship between serum interleukins and T-lymphocyte subsets in patients with severe acute respiratory syndrome Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis Contribution of cytokines to tissue damage during human respiratory syncytial virus infection Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies Cytokines induced during influenza virus infection Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium Human rhinovirus induced cytokine/chemokine responses in human airway epithelial and immune cells The deadly coronaviruses: the 2003. SARS pandemic and the 2020 novel coronavirus epidemic in China Evaluation and Treatment Coronavirus (COVID-19) CDC. Influenza Vaccines -United States Rhinovirus vaccination: the case against Review of the clinical characteristics of Coronavirus Disease 2019. (COVID-19) Available online at Respiratory syncytial virus: diagnosis, treatment and prevention Update on human rhinovirus and coronavirus infections Coronavirus-associated pneumonia in previously healthy children Clinical disease in children associated with newly described coronavirus subtypes Identification of a novel coronavirus in patients with severe acute respiratory syndrome Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed Coronavirus Disease Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area Gender differences in patients with COVID-19: focus on severity and mortality Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis Structure, function, and evolution of coronavirus spike proteins Angiotensin-I-converting enzyme and its relatives Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters A novel coronavirus associated with severe acute respiratory syndrome Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV Airway Epithelial Differentiation and Mucociliary Clearance Respiratory epithelial cells orchestrate pulmonary innate immunity The role of toll-like receptors in the production of cytokines by human lung macrophages Lung epithelial cells: therapeutically inducible effectors of antimicrobial defense Pulmonary macrophages: key players in the innate defence of the airways The development and function of lungresident macrophages and dendritic cells Contribution of dendritic cells in protective immunity against respiratory syncytial virus infection The contributions of lung macrophage and monocyte heterogeneity to influenza pathogenesis Plasmacytoid dendritic cells: development, regulation, and function Human dendritic cell subsets: an update The multifaceted biology of plasmacytoid dendritic cells Role of dendritic cells in SARS coronavirus infection Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting Macrophage polarization in virus-host interactions Macrophages: sentinels and regulators of the immune system Lung dendritic cells at the innate-adaptive immune interface Lung interstitial macrophages: past, present, and future Innate immune response to influenza virus at singlecell resolution in human epithelial cells revealed paracrine induction of interferon lambda 1 The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA Innate immunity in the respiratory epithelium The airway epithelium: soldier in the fight against respiratory viruses Lung epithelial cells have virus-specific and shared gene expression responses to infection by diverse respiratory viruses Helix 1 tryptophan variants in Galleria mellonella apolipophorin III Synergy of IL-27 and TNFalpha in regulating CXCL10 expression in lung fibroblasts SARS-coronavirus replication in human peripheral monocytes/macrophages Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis Molecular mechanisms of cell death: central implication of ATP synthase in mitochondrial permeability transition Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection Exacerbated innate host response to SARS-CoV in aged non-human primates Analysis on 54 mortality cases of Coronavirus Disease 2019 in the Republic of Korea from Prevalence of SARS-CoV antibody in all Hong Kong patient contacts Respiratory syncytial virus Measles virus V protein blocks interferon (IFN)-alpha/beta but not IFN-gamma signaling by inhibiting STAT1 and STAT2 phosphorylation Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3 Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex The severe acute respiratory syndrome coronavirus nucleocapsid inhibits type I interferon production by interfering with TRIM25-mediated RIG-I ubiquitination Neutrophil recruitment and function in health and inflammation Host-pathogen interactions during coronavirus infection of primary alveolar epithelial cells The role of C5a in acute lung injury induced by highly pathogenic viral infections Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome Lung pathology of fatal severe acute respiratory syndrome Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS) Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques Location or origin? What is critical for macrophage propagation of lung fibrosis? Thinsection CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience Pathogenesis of severe acute respiratory syndrome The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes. medRxiv Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2 Mannosebinding lectin in severe acute respiratory syndrome coronavirus infection Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation. medRxiv The case of complement activation in COVID-19 multiorgan impact Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV Neutrophils in viral infections: current concepts and caveats A role for neutrophils in viral respiratory disease. Front Immunol Severe acute respiratory distress syndrome (SARS): a critical care perspective A major outbreak of severe acute respiratory syndrome in Hong Kong Neutrophil-to-lymphocyte ratio predicts severe illness patients with 2019. Novel coronavirus in the early stage Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice Effect of heterophil depletion by 5-fluorouracil on infectious bronchitis virus infection in chickens Neutrophils are needed for an effective immune response against pulmonary rat coronavirus infection, but also contribute to pathology Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? A dynamic variation of pulmonary ACE2 is required to modulate neutrophilic inflammation in response to Pseudomonas aeruginosa lung infection in mice Neutrophil extracellular traps in immunity and disease Neutrophil extracellular traps (NETs) -formation and implications Targeting potential drivers of COVID-19: neutrophil extracellular traps The role of neutrophil extracellular traps in Covid-19: only an hypothesis or a potential new field of research? Autopsy findings and venous thromboembolism in patients with COVID-19 Coagulation abnormalities and thrombosis in patients with COVID-19 Mechanisms underlying neutrophil-mediated monocyte recruitment Partners in crime: neutrophils and monocytes/macrophages in inflammation and disease Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients HLA-Cw7 zygosity affects the size of a subset of CD158b+ natural killer cells The involvement of natural killer cells in the pathogenesis of severe acute respiratory syndrome Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome SARS-CoV-2 infection in children: transmission dynamics and clinical characteristics Will children reveal their secret? The coronavirus dilemma Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses How the SARS coronavirus causes disease: host or organism? Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection Mobile group II introns of yeast mitochondrial DNA are novel site-specific retroelements Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1 SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists SARS coronavirus nsp1 protein induces templatedependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage Middle East respiratory syndrome coronavirus nsp1 inhibits host gene expression by selectively targeting mRNAs transcribed in the nucleus while sparing mRNAs of cytoplasmic origin Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling MERS-CoV papain-like protease has deISGylating and deubiquitinating activities Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease The ADP-ribose-1''-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses Accessory proteins of SARS-CoV and other coronaviruses The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Copyright © 2020 Ahmed-Hassan, Sisson, Shukla, Wijewantha, Funderburg, Li, Hayes, Demberg and Liyanage. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.